Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ВО «Чувашский государственный университет им. И.Н. Ульянова», Чебоксары, Россия tlarisagast18@mail.ru
Список исп. литературыСкрыть список 1. Busuttil RA, George J, House CM et al. SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence. Gastric Cancer. 2021; 24 (3): 589–601. DOI: 10.1007/s10120-020-01143-8 2. Tinazzi I, Mulipa P, Colato C et al. SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker. J Clin Med. 2021; 10 (24): 5820. DOI: 10.3390/jcm10245820 3. Sandsmark E, Andersen MK, Bofin AM et al. SFRP4 gene expression is increased in aggressive prostate cancer. Sci Rep. 2017; 7 (1): 14276. DOI: 10.1038/s41598-017-14622-3 4. Nfonsam LE, Jandova J, Jecius HC et al. SFRP4 expression correlates with epithelial mesenchymal transition-linked genes and poor overall survival in colon cancer patients. World J Gastrointest Oncol. 2019; 11 (8): 589–98. DOI: 10.4251/wjgo.v11.i8.589 5. Colletti A, Pellizzato M, Cicero AF. The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review. Microorganisms. 2023; 11 (9): 2160. DOI: 10.3390/microorganisms11092160 6. Searle T, Ali FR, Carolides S, Al-Niaimi F. Rosacea and the gastrointestinal system. Australas J Dermatol. 2020; 61 (4): 307–11. DOI: 10.1111/ajd.13401 7. Wang FY, Chi CC. Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut-Skin Axis of Rosacea. Adv Ther. 2021; 38 (3): 1415–24. DOI: 10.1007/s12325-021-01624-x 8. Aghaei M, Aghaei S, Behshadnia F et al. Association between the Treatment of Rosacea and Eradication of Helicobacter Pylori Infection. Adv Biomed Res. 2023; 12: 173. DOI: 10.4103/abr.abr_ 236_22 9. Phan K, Onggo J, Charlton O, Smith SD. Relationship between psoriasis and non-alcoholic fatty liver disease – Updated systematic review and adjusted meta-analysis. Australas J Dermatol. 2019; 60 (4): e352–e355. DOI: 10.1111/ajd.13015 10. Abedini R, Salehi M, Lajevardi V, Beygi S. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clin Exp Dermatol. 2015; 40 (7): 722–7. DOI: 10.1111/ced.12672 11. Ganzetti G, Campanati A, Offidani A. Non-alcoholic fatty liver disease and psoriasis: So far, so near. World J Hepatol. 2015; 7 (3): 315–26. DOI: 10.4254/wjh.v7.i3.315 12. Narayanasamy K, Sanmarkan AD, Rajendran K et al. Relationship between psoriasis and non-alcoholic fatty liver disease. Prz Gastroenterol. 2016; 11 (4): 263–69. DOI: 10.5114/pg.2015.53376 13. Лыкова С.Г., Спицына А.В., Моржанаева М.А. Метаболический синдром и псориаз как коморбидные состояния. Дальневосточный медицинский журнал. 2017; 1: 93–8. Lykova SG, Spitsyna AV, Morzhanaeva MA. Metabolic syndrome and psoriasis as comorbid conditions. Dalnevostochnyj Medicinskij Zhurnal – Far Eastern Med J. 2017; 1: 93–8 (in Russian).